|
VAMP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.699200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.328210E-02 |
| Normal-vs-Stage2 |
4.003800E-01 |
| Normal-vs-Stage3 |
1.416660E-03 |
| Normal-vs-Stage4 |
3.815600E-04 |
| Stage1-vs-Stage2 |
3.471400E-01 |
| Stage1-vs-Stage3 |
1.915170E-01 |
| Stage1-vs-Stage4 |
7.137800E-02 |
| Stage2-vs-Stage3 |
1.097440E-01 |
| Stage2-vs-Stage4 |
4.379900E-02 |
| Stage3-vs-Stage4 |
4.590000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.398110E-03 |
| Normal-vs-AfricanAmerican |
8.411700E-02 |
| Normal-vs-Asian |
1.304490E-02 |
| Caucasian-vs-AfricanAmerican |
6.870800E-01 |
| Caucasian-vs-Asian |
9.773800E-01 |
| AfricanAmerican-vs-Asian |
7.400400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.602200E-03 |
| Normal-vs-Female |
7.161800E-03 |
| Male-vs-Female |
6.497000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.726400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.184900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.040470E-02 |
| Normal-vs-Age(81-100Yrs) |
1.332410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.904100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.691800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.521400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.949800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.324800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.102400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.123800E-01 |
| Classical-VS-Follicular |
3.027200E-01 |
| Classical-VS-Other |
2.703200E-01 |
| Classical-VS-Normal |
6.218000E-03 |
| Tall-VS-Follicular |
3.575200E-01 |
| Tall-VS-Other |
3.460400E-01 |
| Tall-VS-Normal |
3.458400E-02 |
| Follicular-VS-Other |
2.526200E-01 |
| Follicular-VS-Normal |
1.864560E-01 |
| Other-VS-Normal |
2.878400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.220710E-03 |
| Normal-vs-N1 |
9.001700E-04 |
| N0-vs-N1 |
3.030200E-01 |
|
|
